CAPR vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

CAPR

46.2
AI Score
VS
CAPR Wins

CBIO

45.5
AI Score

Investment Advisor Scores

CAPR

46score
Recommendation
HOLD

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CAPR CBIO Winner
Revenue 11.14M 1.04M CAPR
Net Income -33.35M -48.12M CAPR
Net Margin -299.4% -4631.4% CAPR
Operating Income -34.87M -51.09M CAPR
ROE -48.9% -29.5% CBIO
ROA -35.9% -26.3% CBIO
Total Assets 92.95M 182.76M CBIO
Cash 68.38M 171.59M CBIO
Current Ratio 4.19 9.66 CBIO
Free Cash Flow -25.88M -28.56M CAPR

Relative Price Performance (Last 90 Days)

CAPR 1M: -81.8% · 3M: -87.5% CBIO 1M: -13.0% · 3M: -17.7%

Current Technical Phase

CAPR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -21.1%), weak momentum, RSI 13

RSI (14): 13.1 · Price: $4.20

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $14.87

Fundamentals Snapshot

Metric CAPR CBIO
Market Cap
Forward P/E -3.3 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.0%
Gross Margin -8.3% 1.0%
Operating Margin 0.0% -14.3%
EPS -2.32 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CAPR is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.